Navigation Links
Inovio Pharmaceuticals to Present at Scientific Conferences
Date:3/29/2011

sults achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, our ability to successfully integrate Inovio and VGX Pharmaceuticals, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2010 and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACTS:Investors: Bernie Hertel, Inovio Pharmaceuticals 858-410-3101 bhertel@inovio.com

Media
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
2. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
3. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
4. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
5. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
6. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
7. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
8. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
9. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
10. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
11. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Investor-Edge has initiated coverage on ... Horizon Pharma PLC (NASDAQ: HZNP ), Endocyte Inc. ... JNJ ), and Theravance Inc. (NASDAQ: THRX ... at: http://investor-edge.com/register . On Tuesday, November 25, ... Dow Jones Industrial Average edged 0.02% lower, to finish the ...
(Date:11/26/2014)... Pa. , Nov. 26, 2014 ... to the development of innovative transdermal synthetic cannabinoid treatments, ... Piper Jaffray 26th Annual Healthcare Conference 2014. The conference ... New York Palace in New York ... will present at 4:50 pm on Tuesday, December 2. ...
(Date:11/26/2014)... and LONDON , Nov. ... market intelligence, MarketResearch.com is pleased to announce the distribution ... Consultancy focusing on the active pharmaceutical ingredient (API) market. ... http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . In IQ4I,s newest ... Forecast to 2020 , IQ4I analysts ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Biotechnology Company updates progress and upcoming,milestones on ... 2007 /PRNewswire-FirstCall/ - SemBioSys,Genetics Inc. , a ... for metabolic and cardiovascular disease,today announced positive ... human insulin. The Company,presented its findings at ...
... Tolerability Profile,in Subjects with Type 2 Diabetes ... /PRNewswire-FirstCall/ -- Phase III data,presented this week ... Diabetes,Association demonstrated that saxagliptin, an inhibitor of,dipeptidyl-peptidase-4 ... BMY) and AstraZeneca (NYSE: AZN), in,combination with ...
Cached Medicine Technology:SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6
(Date:11/28/2014)... A newly released article from ... the influenza virus that will soon be spreading across the ... article begins with a brief explanation of what the influenza ... families that children under the age of 5, adults over ... such as heart and lung diseases, asthma, or diabetes, are ...
(Date:11/28/2014)... Georgia (PRWEB) November 28, 2014 Patten ... and locally grown. With those passions driving them, they've ... Georgia Grown. Having tried other pecans oils, they've found ... Pitts, Georgia to be exceptionally flavorful, retaining the buttery ... The same nutritional benefits found in pecans ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic and ... to its students. That is why the Virginia ... structure at its mental health services facility in ... for children who are identified as needing additional ... served the needs of children with severe emotional ...
(Date:11/28/2014)... talklocal ( http://www.talklocal.com ) is launching in ... by phone in about 90 seconds. , The launch ... reported to have touched down just north of the city ... tornadoes, Denver residents now know all too well the value ... having local pros in over 50 service categories on speed ...
(Date:11/28/2014)... 2014 Nipomo Family Dentistry , ... recently opened its doors at 195 N. Thompson St., ... preventative care like teeth cleanings, oral exams, fillings, implants ... teeth whitening (and Kor whitening), laser whitening, gum tissue ... Family Dentistry’s five-person team also takes a philanthropic approach ...
Breaking Medicine News(10 mins):Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3Health News:TalkLocal Launches In Denver A Week After Multiple Tornadoes Hit Near City 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 3
... 1 Oral Session and 21 Poster Sessions ... Debuts New Clostridium difficile Program , LOUISVILLE, Colo., ... today that it will be presenting 21 posters,highlighting three ... Antimicrobial Agents and Chemotherapy (ICAAC) held at the,McCormick Place ...
... Centers to Offer Free Health Assessments, HARRISBURG, Pa., ... invited Pennsylvanians to take advantage of,free health assessments being ... Sept. 21. The free health services are available in,conjunction ... which is observed on,Sept. 18., "Nearly 800,000 Pennsylvanians ...
... to Lead Financing Strategies to Fund Growth, ... Bulletin Board: APHY) today announced that it has ... EFH ) to develop and,lead financing strategies. Assured ... for patients with chronic pain and other,long-term care ...
... strengthen brand recognition, national ... BUFFALO, N.Y., Sept. 17 Meritain Health, ... today announced,the name change of recently acquired benefits ... of Meritain Health. Meritain Health acquired Weyco ...
... 17 LifeNet Health, a leading,biomedical and allograft ... Wound Allograft Institute" in affiliation with The Living ... and most progressive,organ and tissue recovery organizations in ... Institute" will directly serve the needs of burn,patients ...
... asthma type, study concludes, , , MONDAY, Sept. 17 ... the type of asthma you develop, new research ... in affluent, developed countries had more allergy-triggered asthma ... countries. , "The link between atopic sensitization ...
Cached Medicine News:Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 5Health News:Assured Pharmacy Retains Empire Financial Group 2Health News:Assured Pharmacy Retains Empire Financial Group 3Health News:Meritain Health Announces Name Change for Acquired Companies 2Health News:LifeNet Health Establishes 'The Skin & Wound Allograft Institute' 2Health News:Allergy-Induced Asthma More Common in Affluent Countries 2Health News:Allergy-Induced Asthma More Common in Affluent Countries 3
... Gellhorn Pessary is used for ... prolapse, or procidentia. It has ... and comes in nine sizes. ... easily folds over for insertion, ...
... are among the smallest and ... with advanced reporting software that ... information. Extensive testing by independent ... accuracy, making it widely recognized ...
Low Profile Design for Precise Anchor Placement...
... is a minimally invasive treatment option ... urinary incontinence (SUI). The Monarc treats ... abdominal stress events, such as sneezing, ... approach avoids the retropubic space.Monarc's transobturator ...
Medicine Products: